Drug
Bms 986177
Bms 986177: highest development phase Phase 1, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| BMS-986177 NCT03362437 | Phase 1 | Thrombosis |
Latest
No recent events.
Follow Bms 986177 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.